| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENFN | Class A Common Stock | +Grant/Award | $0 | +13,470 | +39.08% | $0.00 | 47,941 | Jun 13, 2024 | Direct | F1 |
| transaction | ENFN | Class A Common Stock | -Sell | -$38,884 | -4,629 | -9.66% | $8.40 | 43,312 | Jun 14, 2024 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full on the earlier of June 13, 2025, or the date of the 2025 annual meeting of stockholders of the issuer. |
| F2 | Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person. |
| F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.35 to $8.49. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request. |